speb/financial-data huggingface dataset:
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Goodwill: 416200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1272800000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2216900000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 47277200000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 19567900000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 1583600000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1583600000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Interest Income: 136100000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 136100000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1755600000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 125600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: -22500000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 3075400000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 33831000000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1875100000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 460900000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 958600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 4618100000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 16400000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 10919100000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 10935500000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 958600000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1257600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 118600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 30998600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 784700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Minority Interests: 86900000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 12747000000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -7800000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Income: -433600000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -433600000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -520500000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -433600000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -433600000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -841200000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -520500000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -1712200000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 542100000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -338700000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -299000000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1712200000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -7900000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -542000000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 31377000000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 257100000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -39700000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 18139400000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 1404600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 1079900000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 118600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 675100000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2349000000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Normalized Income: -764326640.51
SAGCEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 4004000000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Operating Income: 326200000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 24982500000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 130707548.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 734200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 514200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 19150800000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 856600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 1041800000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1563300000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 261100000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 1205200000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 3000000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 10562200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 204500000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 3212800000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 169200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1034700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -73700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Payables: 5492600000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 90000000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 54700000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 639500000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Pretax Income: -841200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 95000000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -542000000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 872700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5414600000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2141100000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 26100000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 26100000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1297300000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 949400000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 6216500000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 542100000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 257100000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 5154700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 5392000000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 130707548.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -39700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 216600000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 19412200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 18139400000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 203773359.49
SAGCEM.NS income_statement (annual, 2024-03-31) — Tax Provision: -320700000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.38
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 25000000.00
SAGCEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -96400000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 43562100000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 30331300000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 14440800000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 20196900000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 24656300000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 23365200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 34940900000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 13339200000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 264700000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 101800000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 534500000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 534500000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 946200000.00
SAGCEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: -1404800000.00
SAGCEM.NS income_statement (annual, 2024-03-31) — Write Off: -142900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 5048800000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2545700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 13300000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 487100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 51000000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 261400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 28100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1694300000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 261400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 18476700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 591700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 7649700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 11400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 4724500000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 4735900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 11000900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 53600000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 416200000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 421600000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 31947400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 2969500000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 33300100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 487100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 39600000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 10098900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 10138500000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 144900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 732600000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 14795300000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 31947400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 18055100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 1621000000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 917900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 130707548.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 411100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 743300000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 18215300000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 5400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 239200000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 65600000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 30523900000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 8400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1666200000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 5127500000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Properties: 831800000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 130707548.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 18476700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 18055100000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 7400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 42509700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 28575600000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 14874400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 19209300000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 23300400000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 34860000000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 12299500000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 78700000.00
SAGCEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -3351200000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 4827800000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 5638800000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 132062350.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: -4.17
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1020700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 586100000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 586100000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 132062350.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: -4.17
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -550700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — EBIT: -161600000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — EBITDA: 424500000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 4618100000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 480700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 480700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -6200000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Income: -550700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -550700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -544500000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -550700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -550700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -544500000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -480700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -480700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 424500000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: -550700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Operating Income: -209700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 5638800000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 48100000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 2716300000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: -642300000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1020700000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 586100000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 1149600000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1149600000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: -97800000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.15
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 5848500000.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
SAGCEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SAGCEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 17181400000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 5573300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 21975700000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 6580400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 5545000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5545000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2041700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2041700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -17618800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -17618800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 8835100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 8835100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -126700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -126700000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Amortization: 39000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 39000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 0.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 492000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 492000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 130707548.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 126601073.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Basic EPS: -16.58
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -5.59
SAGCEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1671800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 8293900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 8293900000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1381500000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -1381500000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 178000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 178000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 261400000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 261400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 704900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 704900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 704900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 704900000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -91500000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 654900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 654900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 50000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 50000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 328300000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 144300000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -23000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 603600000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 48500000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 1143500000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -966900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 261400000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 261400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 17228100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 17228100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1232400000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1232400000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 5666400000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1222500000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 6963700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 6963700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 46200000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 46200000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 4364900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 4364900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4411100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4411100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 11990700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 11990700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 48700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 48700000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 2268500000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 2307500000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 2307500000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 583600000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 2268500000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 583600000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 130707548.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 126601073.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: -16.58
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -5.59
SAGCEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -2097900000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -707700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 3000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 3000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — EBIT: -1255200000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — EBIT: -452300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — EBITDA: 1052300000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 131300000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 704900000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -2172900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 255500000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 255500000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 957800000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 8500000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -51400000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 257000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Goodwill: 416200000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 416200000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1233800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1233800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2168400000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2168400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 48702600000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 48702600000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 16309300000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 5357900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 0.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 1580100000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 473100000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1580100000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 473100000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Interest Income: 159000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 159000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1921300000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 148100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 2736000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2736000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 31508100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 31508100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1133300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 492000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 492000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 461200000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 4632800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 4632800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 131800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 131800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 9915100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 9915100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10046900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10046900000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 461200000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1597100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 77200000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 77200000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 31343400000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 31343400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 715200000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 715200000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Minority Interests: 68900000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 22800000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 13575100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 13575100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -2900000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Income: -2097900000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Income: -707700000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -2097900000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -707700000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -2166800000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -730500000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2097900000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -707700000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2097900000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -707700000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -2835300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -2166800000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -730500000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1722300000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -473100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 17100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -117100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -1135900000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1722300000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -473100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 31083800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 31083800000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 82200000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 1018800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 15994300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 15994300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Accrued Expenses: 0.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 0.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 1545800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1545800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 556000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 556000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 158300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 158300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 720000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 720000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1292500000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 403000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Normalized Income: -1914333760.10
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -493223179.17
SAGCEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 2339300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Operating Income: -872100000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: -215400000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 21975700000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 6580400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 130707548.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 130707548.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 445000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 445000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 670900000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 670900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 16966700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 16966700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 817600000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 817600000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 671000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 671000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 1722100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 274100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 274100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 974300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 974300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 2200000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 34800000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 8958400000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3257700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 558300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 558300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 3200100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3200100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 66600000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 66600000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1030800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1030800000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: 213400000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Payables: 6165800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 6165800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 48700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 48700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 449200000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 449200000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Pretax Income: -2835300000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -925400000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 90900000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -49900000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 909700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 909700000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 5666400000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1222500000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2307500000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 583600000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 27000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 27000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1597100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 937600000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 937600000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 4027100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4027100000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 67000000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 82200000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 4887800000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1388300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 5144800000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1388300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 130707548.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 130707548.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 1018800000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: -231700000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -271700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 17228100000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 17228100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 15994300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 15994300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -56633760.10
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -57223179.17
SAGCEM.NS income_statement (annual, 2025-03-31) — Tax Provision: -668500000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -194900000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.24
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 27700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 27700000.00
SAGCEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -44100000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 41766000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 41766000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 27143200000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 27143200000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 14458000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 14458000000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 17943300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 17943300000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 22847800000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 6795800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 23822700000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 23822700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 34802300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 34802300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 11832000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 11832000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 301200000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 59500000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 59500000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -240200000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -271700000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -240200000.00
SAGCEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -271700000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 19300000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 19300000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 899800000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 899800000.00
SAGCEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: -5027000000.00
SAGCEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -5027000000.00
SAGCEM.NS income_statement (annual, 2025-03-31) — Write Off: 18300000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 5200200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 6706600000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 130707548.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.57
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 838400000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 546500000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 546500000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 130707548.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.57
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 12200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 709900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1256400000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 5868200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 470900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 470900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -62700000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 12200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 12200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 74900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 12200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 12200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 74900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -470900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -470900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1256400000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 12200000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 668000000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 6706600000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 41900000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3018800000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 239000000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 838400000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 546500000.00
SAGCEM.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1295000000.00